Pathology and imaging business Healius has posted a 44.2 per cent surge in revenue in the half-year to $1.34 billion and more than trebled its net profit amid a COVID-19 testing boom.

Even as the country shifts to a “living with COVID-19” position where restrictions and testing requirements are less onerous, chief executive Malcolm Parmenter says there will still be a base load of virus testing required.